Skip to main content
 

Contact Us

The Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios. For access to biosimilars experts and information, please contact us and sign up for updates.

Biosimilars Forum
Washington, DC 20006

For questions about the Biosimilars Forum, contact:
Molly Burich
Molly.Burich@boehringer-ingelheim.com

Juliana Reed
Juliana.reed@pfizer.com

For media inquiries, contact:
Anthony Hogrebe
Cell: 732.841.2823

Follow us on Twitter:
@USbiosimilars